Latest Period
Q2 2026
Security Snapshot
Drugs Made In America Acquisition Corp. - Class A Ordinary Shares, par value $0.0001 per share ("Ordinary Shares") (DMAA) Institutional Ownership
CUSIP: G2847J104
13F Institutional Holders and Ownership History from Q1 2025 to Q2 2026
Institutions Reporting
23
Shares (Excl. Options)
11,963,903
Price
$10.65
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share ("Ordinary Shares")
- Symbol
- DMAA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 11,963,903
- Total 13F value
- $124,876,159
- Portfolio coverage rank
- 0%
- Share change
- -10,918,707
- Value change
- -$115,510,947
- Number of holders
- 23
- Shares outstanding
- 24,273,426
- SEC-reported price per share
- $10.68
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- DMAA - Drugs Made In America Acquisition Corp. - Class A Ordinary Shares, par value $0.0001 per share ("Ordinary Shares") is tracked under CUSIP G2847J104.
- 23 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 38 to 23 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $236,043,075 to $124,876,159.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 23 institutions filings for Q2 2026.
Security key
G2847J104
Latest holder period
Q2 2026
13F holders
23
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
DMAA full holder history
Drugs Made In America Acquisition Corp. SEC filings
Drugs Made In America Acquisition Corp. company facts
Drugs Made In America Acquisition Corp. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G2847J104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
DMAA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | 12% | $42,139,127 | 4,188,780 | Drugs Made In America Acquisition LLC | 18 Feb 2025 | |||
| Karpus Management, Inc. | 10% | +27% | $26,783,486 | -$2,523,599 | 2,507,817 | -8.6% | KARPUS MANAGEMENT, INC. | 30 Jun 2026 |
| MIZUHO FINANCIAL GROUP INC | 8.5% | +42% | $21,985,901 | +$625,901 | 2,058,605 | +2.9% | Mizuho Financial Group, Inc. | 30 Jun 2026 |
| Polar Asset Management Partners Inc. | 5.7% | $19,114,000 | 1,900,000 | Polar Asset Management Partners Inc. | 31 Mar 2025 | |||
| Hudson Bay Capital Management LP | 4.6% | -15% | $15,918,500 | -$2,567,500 | 1,550,000 | -14% | Hudson Bay Capital Management LP | 30 Sep 2025 |
| Feis Equities LLC | 5.1% | $12,993,448 | 1,232,775 | Feis Equities LLC | 18 Jun 2026 | |||
| GLAZER CAPITAL, LLC | 4.1% | -26% | $10,678,921 | -$8,790,206 | 999,899 | -45% | Glazer Capital, LLC | 30 Jun 2026 |
| First Trust Capital Management L.P. | 3.2% | -49% | $8,399,382 | -$13,672,995 | 786,459 | -62% | First Trust Capital Management L.P. | 30 Jun 2026 |
As of 30 Jun 2026, 23 institutional investors reported holding 11,963,903 shares of Drugs Made In America Acquisition Corp. - Class A Ordinary Shares, par value $0.0001 per share ("Ordinary Shares") (DMAA). This represents 49% of the company’s total 24,273,426 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
49%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Karpus Management, Inc. | 10% | 2,507,817 | -0.9% | 0.77% | $26,708,251 |
| MIZUHO SECURITIES USA LLC | 8.5% | 2,069,605 | +3.5% | 0.33% | $21,930,113 |
| Polar Asset Management Partners Inc. | 4.7% | 1,146,000 | -28% | 0.22% | $12,204,900 |
| GLAZER CAPITAL, LLC | 4.1% | 999,899 | -40% | 0.26% | $10,649,000 |
| WOLVERINE ASSET MANAGEMENT LLC | 3.4% | 832,093 | -46% | 0.12% | $8,861,790 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3.3% | 809,054 | -39% | 0.29% | $8,616,425 |
| First Trust Capital Management L.P. | 3.2% | 786,459 | -65% | 0.49% | $8,375,788 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 2.7% | 648,083 | -0.29% | 1.6% | $6,902,084 |
| Westchester Capital Management, LLC | 2.4% | 581,790 | -65% | 0.31% | $6,196,063 |
| Clear Street Group Inc. | 1.6% | 382,440 | 0% | 0.01% | $1,645,529 |
| ARISTEIA CAPITAL, L.L.C. | 1.4% | 350,000 | -60% | 0.06% | $3,727,500 |
| SONA ASSET MANAGEMENT (US) LLC | 0.67% | 162,795 | 0% | 0.06% | $1,733,767 |
| RLH Capital LLC | 0.48% | 115,606 | -63% | 0.59% | $1,231,204 |
| Logan Stone Capital, LLC | 0.45% | 109,959 | 0.25% | $1,171,063 | |
| TORONTO DOMINION BANK | 0.41% | 100,000 | -51% | 0% | $1,065,000 |
| Meteora Capital, LLC | 0.4% | 97,837 | -74% | 0.09% | $1,041,964 |
| Quarry LP | 0.27% | 65,551 | -75% | 0.11% | $698,118 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.26% | 62,273 | 0% | 0% | $663,207 |
| JPMORGAN CHASE & CO | 0.21% | 49,891 | +0.02% | 0% | $531,339 |
| Dakota Wealth Management | 0.15% | 36,400 | 0% | 0.01% | $387,660 |
| Lineage Point Capital LP | 0.13% | 31,840 | 0% | 0.07% | $339,096 |
| HRT FINANCIAL LP | 0.08% | 18,483 | -33% | 0% | $196,000 |
| MORGAN STANLEY | 0% | 28 | -52% | 0% | $298 |
| WHITEBOX ADVISORS LLC | 0% | 0 | -100% | $0 | |
| Warberg Asset Management LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q2 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 11,963,903 | $124,876,159 | -$115,510,947 | $10.65 | 23 |
| 2026 Q1 | 22,514,907 | $236,043,075 | -$929,603 | $10.48 | 38 |
| 2025 Q4 | 22,313,763 | $231,075,647 | +$10,437,875 | $10.37 | 38 |
| 2025 Q3 | 22,407,322 | $230,112,841 | +$8,645,514 | $10.27 | 38 |
| 2025 Q2 | 20,823,195 | $212,304,432 | +$35,784,995 | $10.20 | 32 |
| 2025 Q1 | 16,949,502 | $169,795,617 | +$169,795,617 | $10.02 | 23 |